ColdQuanta
Tyler Brous is currently a board member at ColdQuanta. Tyler has also previously served as a board member at CerSci Therapeutics Inc from January 2018 to August 2020. In this role, they helped the company get acquired by Acadia Pharmaceuticals for $52.5 million in Acadia stock and up to $887 million in development, commercialization and sales milestones. Prior to that, they were an analyst at YX Funds from January 2007 to December 2011 and an investment banking analyst - M&A at Citi from January 2005 to December 2007.
Tyler Brous completed a Bachelor of Business Administration (BBA) at The University of Texas at Austin, with a focus in Business Honors & Finance.
This person is not in the org chart
This person is not in any offices
ColdQuanta
ColdQuanta is the leader in Cold Atom Quantum Technology, the most scalable, versatile, and commercially viable area of quantum. Coldquanta is dedicated to making quantum matter through the commercial availability of Quantum Computing, Sensing, and Networking Applications.